PLAU and lung cancer: It also inhibits the expression levels of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9), and urokinase-type plasminogen activator (uPA), contributing to the inhibition of the proliferation, invasion, and migration of lung cancer cells (130) (Figure 3).